Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer
Md Shakir Uddin Ahmed,1 Ahmad Bin Salam,1 Clayton Yates,1 Kyle Willian,2 Jesse Jaynes,3 Timothy Turner,4 Mohamed O Abdalla5 1Department of Biology, Tuskegee University, Tuskegee, 2Department of Chemistry and Biochemistry, Auburn University, Auburn, 3Department of Environmental Sciences, Tuskegee Un...
Enregistré dans:
Auteurs principaux: | Ahmed MSU, Salam AB, Yates C, Willian K, Jaynes J, Turner T, Abdalla MO |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/25c205f28366477c9cc5f03a918d9fa8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin
par: Oh F, et autres
Publié: (2018) -
Treatment patterns and survival in metastatic castration‐sensitive prostate cancer in the US Veterans Health Administration
par: Stephen J. Freedland, et autres
Publié: (2021) -
The Urokinase Receptor (uPAR) as a “Trojan Horse” in Targeted Cancer Therapy: Challenges and Opportunities
par: Virginia Metrangolo, et autres
Publié: (2021) -
Antitumor Activity and Mechanism of Action of Hormonotoxin, an LHRH Analog Conjugated to Dermaseptin-B2, a Multifunctional Antimicrobial Peptide
par: Mickael Couty, et autres
Publié: (2021) -
Gross Anatomical, Histological and Histochemical Studies on the Postnatal Development of the Prostate Gland of Gaddi Goat
par: Pathak,Archana, et autres
Publié: (2012)